Neonatal jaundice causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Causes) |
||
Line 28: | Line 28: | ||
***[[Hemolytic disease of the newborn (ABO)]] | ***[[Hemolytic disease of the newborn (ABO)]] | ||
***[[Rh disease]] | ***[[Rh disease]] | ||
===Non-hemolytic causes | === Less common causes === | ||
*[[Cephalohematoma]] | * Less common causes of neonatal jaundice include the following disorders: | ||
*[[Polycythemia]] | ** Non-hemolytic causes | ||
*[[Sepsis]] | ***[[Cephalohematoma]] | ||
*[[Hypothyroidism]] | ***[[Polycythemia]] | ||
*[[Gilbert's syndrome]] | ***[[Sepsis]] | ||
*[[Crigler-Najjar syndrome]] | ***[[Hypothyroidism]] | ||
***[[Gilbert's syndrome]] | |||
***[[Crigler-Najjar syndrome]] | |||
* Hepatic causes | |||
*Infections | **Infections | ||
**[[Sepsis]] | ***[[Sepsis]] | ||
**[[Hepatitis B]], [[TORCH syndrome|TORCH infections]] | ***[[Hepatitis B]], [[TORCH syndrome|TORCH infections]] | ||
*Metabolic | **Metabolic | ||
**[[Galactosemia]] | ***[[Galactosemia]] | ||
**[[Alpha-1-antitrypsin deficiency]] | ***[[Alpha-1-antitrypsin deficiency]] | ||
**[[Cystic fibrosis]] | ***[[Cystic fibrosis]] | ||
*Drugs- [[Losartan and Hydrochlorothiazide]] | **Drugs- [[Losartan and Hydrochlorothiazide]] | ||
*[[Total parenteral nutrition]] | **[[Total parenteral nutrition]] | ||
*Idiopathic | **Idiopathic | ||
* Post-hepatic | |||
*[[Biliary atresia]]<ref>{{cite journal|last=Kumral|first=A|coauthors=Ozkan H, Duman N, et al.|title=Breast milk jaundice correlates with high levels of epidermal growth factor|journal=Pediatr Res|year=2009|volume=66|pages=218–21}}</ref><ref>{{cite journal|last=Arias|first=IM|coauthors=Gartner LM, Seifter S, Furman M|title=Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steroid, pregnane-3(alpha), 20(beta)-diol in maternal milk that inhibits glucuronide formation in vitro.|journal=J Clin Invest|year=1964|volume=43|pages=2037–47}}</ref> | **[[Biliary atresia]]<ref>{{cite journal|last=Kumral|first=A|coauthors=Ozkan H, Duman N, et al.|title=Breast milk jaundice correlates with high levels of epidermal growth factor|journal=Pediatr Res|year=2009|volume=66|pages=218–21}}</ref><ref>{{cite journal|last=Arias|first=IM|coauthors=Gartner LM, Seifter S, Furman M|title=Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steroid, pregnane-3(alpha), 20(beta)-diol in maternal milk that inhibits glucuronide formation in vitro.|journal=J Clin Invest|year=1964|volume=43|pages=2037–47}}</ref> | ||
*[[Bile duct]] obstruction<ref>{{cite journal|last=Murphy|first=J F|coauthors=Hughes I, Verrier Jones ER, Gaskell S, Pike AW.|title=Pregnanediols and breast-milk jaundice.|journal=Arch Dis Child|year=1981|volume=56|pages=474–76}}</ref><ref>{{cite journal|last=Poland|first=R L|coauthors=Schultz GE, Gayatri G|title=High milk lipase activity associated with breastmilk jaundice.|journal=Pediatr Res|year=1980|volume=14|pages=1328–31}}</ref> | *[[Bile duct]] obstruction<ref>{{cite journal|last=Murphy|first=J F|coauthors=Hughes I, Verrier Jones ER, Gaskell S, Pike AW.|title=Pregnanediols and breast-milk jaundice.|journal=Arch Dis Child|year=1981|volume=56|pages=474–76}}</ref><ref>{{cite journal|last=Poland|first=R L|coauthors=Schultz GE, Gayatri G|title=High milk lipase activity associated with breastmilk jaundice.|journal=Pediatr Res|year=1980|volume=14|pages=1328–31}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 16:29, 30 January 2018
Neonatal jaundice Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neonatal jaundice causes On the Web |
American Roentgen Ray Society Images of Neonatal jaundice causes |
Risk calculators and risk factors for Neonatal jaundice causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Neonatal jaundice is caused by hemolysis of the RBCs mainly due to either intravascular causes or extravascular causes. Other causes include nonhemolytic causes as cephalosporines induced jaundice, genetic mutaitons of the UGT enzyme, and hepatic causes.
Causes
Common causes
- Common causes of neonatal jaundice include the following:
- Increase bilirubin production due to hemolysis. Hemolytic causes include the following:
- Intrinsic causes of hemolysis:
- Systemic contitions:
- Enzyme conditions
- Glucose-6-phosphate dehydrogenase deficiency (also called G6PD deficiency)
- Pyruvate kinase deficiency
- Globin synthesis defect
- Extrinsic causes of hemolysis:
- Alloimmunity (The neonatal or cord blood gives a positive direct Coombs test and the maternal blood gives a positive indirect Coombs test)
- Hemolytic disease of the newborn (ABO)
- Rh disease
- Extrinsic causes of hemolysis:
Less common causes
- Less common causes of neonatal jaundice include the following disorders:
- Non-hemolytic causes
- Hepatic causes
- Infections
- Metabolic
- Drugs- Losartan and Hydrochlorothiazide
- Total parenteral nutrition
- Idiopathic
References
- ↑ Kumral, A (2009). "Breast milk jaundice correlates with high levels of epidermal growth factor". Pediatr Res. 66: 218–21. Unknown parameter
|coauthors=
ignored (help) - ↑ Arias, IM (1964). "Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steroid, pregnane-3(alpha), 20(beta)-diol in maternal milk that inhibits glucuronide formation in vitro". J Clin Invest. 43: 2037–47. Unknown parameter
|coauthors=
ignored (help) - ↑ Murphy, J F (1981). "Pregnanediols and breast-milk jaundice". Arch Dis Child. 56: 474–76. Unknown parameter
|coauthors=
ignored (help) - ↑ Poland, R L (1980). "High milk lipase activity associated with breastmilk jaundice". Pediatr Res. 14: 1328–31. Unknown parameter
|coauthors=
ignored (help)